Advanced Glycation End Products’ Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Advanced Glycation End Products’ Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Background. Advanced glycation end products’ receptor (AGER) is a multiligand receptor that interacts with a wide range of ligands. Previous studies have shown that abnormal AGER expression is closely related to immune infiltration and tumorigenesis. However, the AGER DNA methylation relationship be...

Full description

Bibliographic Details
Main Authors:	Jun Yang, Mingqiang Lin, Mengyan Zhang, Zhiping Wang, Hancui Lin, Yilin Yu, Qunhao Zheng, Xiaohui Chen, Yahua Wu, Qiwei Yao, Jiancheng Li
Format:	Article
Language:	English
Published:	Hindawi - Cambridge University Press 2023-01-01
Series:	Genetics Research
Online Access:	http://dx.doi.org/10.1155/2023/7129325

Similar Items

CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro
by: Qiwei Yao, et al.
Published: (2022-01-01)

Bioinformatics analysis combined with experiments predicts CENPK as a potential prognostic factor for lung adenocarcinoma
by: Jiayu Ma, et al.
Published: (2021-01-01)

Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
by: Jianjian Qiu, et al.
Published: (2023-05-01)

M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma
by: Junfan Pan, et al.
Published: (2022-11-01)

A New Nomogram and Risk Stratification of Brain Metastasis by Clinical and Inflammatory Parameters in Stage III Small Cell Lung Cancer Without Prophylactic Cranial Irradiation
by: Jianjian Qiu, et al.
Published: (2022-07-01)

A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy
by: Xiaohui Chen, et al.
Published: (2022-06-01)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
by: Lin Li, et al.
Published: (2023-03-01)

Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
by: Qunhao Zheng, et al.
Published: (2021-11-01)

Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy
by: Jianjian Qiu, et al.
Published: (2022-11-01)

The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study
by: Yilin Yu, et al.
Published: (2022-07-01)

The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma
by: Yahua Wu, et al.
Published: (2023-08-01)

GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
by: Jing Ning, et al.
Published: (2021-06-01)

A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study
by: Yilin Yu, et al.
Published: (2022-08-01)

Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy
by: Jianjian Qiu, et al.
Published: (2023-06-01)

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
by: Jinjie Wang, et al.
Published: (2022-06-01)

TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
by: Longbin Guo, et al.
Published: (2020-09-01)

Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy
by: Jun Yang, et al.
Published: (2023-01-01)

Developing CuS for Predicting Aggressiveness and Prognosis in Lung Adenocarcinoma
by: Honghao Liu, et al.
Published: (2023-05-01)

Immune infiltration landscape on prognosis and therapeutic response and relevant epigenetic and transcriptomic mechanisms in lung adenocarcinoma
by: Liangming Zhang, et al.
Published: (2022-10-01)

Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma
by: Haishan Wu, et al.
Published: (2021-10-01)

Neutrophil infiltration associated genes on the prognosis and tumor immune microenvironment of lung adenocarcinoma
by: Renwang Liu, et al.
Published: (2023-12-01)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
by: Xiaoli Zou, et al.
Published: (2022-04-01)

The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma
by: Jingyan Gao, et al.
Published: (2022-10-01)

Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma
by: Guojun Lu, et al.
Published: (2021-06-01)

BTN3A2 Expression Is Connected With Favorable Prognosis and High Infiltrating Immune in Lung Adenocarcinoma
by: Yuansheng Lin, et al.
Published: (2022-07-01)

Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patients
by: Yahua Wu, et al.
Published: (2022-01-01)

Tumor-infiltrating platelets promote the growth of lung adenocarcinoma
by: Xiaohui Li, et al.
Published: (2024-01-01)

Significance of Immunohistochemical Indicators in Diagnosis and Prognosis of  Squamous Cell Carcinoma and Adenocarcinoma of Lung
by: Yunfan MA, et al.
Published: (2014-06-01)

Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma
by: Yueyan Zhu, et al.
Published: (2019-10-01)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
by: Wenting Liu, et al.
Published: (2021-03-01)

Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma
by: Minle Wu, et al.
Published: (2022-10-01)

Measures of lung function and their relationship with advanced glycation end-products
by: Suneela Zaigham, et al.
Published: (2020-06-01)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
by: Yu Zhang, et al.
Published: (2023-08-01)

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas
by: Gang Xiao, et al.
Published: (2023-09-01)

Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma
by: Chenyang Ye, et al.
Published: (2022-10-01)

Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
by: Yan-Qi Li, et al.
Published: (2021-04-01)

SNX20 Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma
by: Wu GJ, et al.
Published: (2021-11-01)

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
by: Lu-Shan Peng, et al.
Published: (2022-11-01)

Analysis of Nucleoporin 107 Overexpression and Its Association with Prognosis and Immune Infiltration in Lung Adenocarcinoma by Bioinformatics Methods
by: Li ZH, et al.
Published: (2023-11-01)

The Ion Channel Gene KCNAB2 Is Associated with Poor Prognosis and Loss of Immune Infiltration in Lung Adenocarcinoma
by: Yin Lyu, et al.
Published: (2022-10-01)